首页 | 本学科首页   官方微博 | 高级检索  
检索        

阿托伐他汀和阿昔莫司联合治疗高脂血症的临床观察
引用本文:吴永杰.阿托伐他汀和阿昔莫司联合治疗高脂血症的临床观察[J].医药论坛杂志,2010(11).
作者姓名:吴永杰
作者单位:中国人民解放军总医院;
摘    要:目的探讨联合应用阿托伐他汀和阿昔莫司治疗混合性高脂血症的临床疗效。方法共入选186例混合性高脂血症患者,随机分入阿托伐他汀组(n=52)、阿昔莫司组(n=54)和联合治疗组(阿托伐他汀+阿昔莫司,n=80)。观察治疗前后主要血脂参数的变化幅度以及不良反应。结果联合治疗组血脂参数变化幅度最显著,血清总胆固醇(TC)、低密度脂蛋白胆固醇(LDL-C)和甘油三酯(TG)均显著下降,而血清高密度脂蛋白胆固醇(HDLC)升高优于阿托伐他汀组和阿昔莫司组(P<0.01)。结论阿昔莫司组与小剂量阿托伐他汀联合治疗可全面调节血脂,有效治疗混合型高脂血症。

关 键 词:高脂血症  阿托伐他汀  阿昔莫司  

Study of Combination Therapy with Acipimox and Atorvastatin for Combined Hyperlipidemia
WU Yongjie General Hospital of Chinese People's Liberation Army,Beijing ,China.Study of Combination Therapy with Acipimox and Atorvastatin for Combined Hyperlipidemia[J].Journal of Medical Forum,2010(11).
Authors:WU Yongjie General Hospital of Chinese People's Liberation Army  Beijing  China
Institution:WU Yongjie General Hospital of Chinese People's Liberation Army,Beijing 100039,China
Abstract:Objective To explore the effect of combination of atorvastatin and acipimox in treatment of mixed hyperlipidemia.Methods A total of 186 cases selected patients with mixed hyperlipidemia were randomly divided into atorvastatin group(n=52),acipimox group(n=54) and the combined treatment group(atorvastatin+acipimox,n=80).Observe the change range of the main lipid parameters and adverse reactions.Results Changes in the treatment of lipid parameters increase most significantly,serum total cholesterol(TC),low den...
Keywords:Hyperlipidemia  Acipimox  Atorvastatin  
本文献已被 CNKI 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号